Obesity-associated diabetes, and concomitant inflammation may compromise pancreatic β-cell integrity and function. L-glutamine and L-alanine are potent insulin secretagogues, with antioxidant and cytoprotective properties. Here we studied whether the dipeptide L-Alanyl-L-Glutamine (Ala-Gln) could exert protective effects via Sirtuin 1/Hur (SIRT1/HUR) signalling in β-cells, against detrimental responses following ex vivo stimulation with inflammatory mediators-derived from macrophages (IMM). The macrophages were derived from blood obtained from obese individuals. Macrophages were exposed (or not) to Lipopolysaccharide (LPS) to generate a pro-inflammatory cytokine cocktail. The cytokine profile was determined following analysis by flow cytometry. Insulin secreting BRIN-BD11 β-cells were exposed to IMM and then cultured with or without Ala-Gln for 24 h. Chronic insulin secretion, L-glutamine-glutathione (GSH) axis, and the level of insulin receptor β (IRβ), Heat shock protein 70 (HSP70), SIRT1/HUR, CCAAT-enhancer-binding protein homologous protein (CHOP) and Cytochrome c Oxidase IV (COX IV) were evaluated. Cytokine concentrations, including IL-1β, IL-6, IL-10 and TNF-α in the IMM was higher following exposure to LPS. Subsequently, when β-cells were exposed to IMM, chronic insulin secretion, IRβ and COX IV levels were decreased, but these effects were partially or fully attenuated by the addition of Ala-Gln. The glutamine-GSH axis and HSP70 levels, which were compromised by IMM, were also restored by Ala-Gln, possibly due to protection of of SIRT1/HUR levels, and a reduction of CHOP expression. Using an ex vivo inflammatory approach, we have demonstrated Ala-Gln dependent β-cell protection mediated by coordinated effects on glutamine-GSH axis, and HSP pathway, maintenance of mitochondrial metabolism and stimulus-secretion coupling essential for insulin release.